Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -0.656% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) Cc1cc(C)c2c(n1)nn1c(NCCN3CCOCC3)cc(C)nc21
b.) Cc1ccc(-c2nnc(N3CCC(C)CC3)c3ccccc23)cc1
Answer: a. Cc1cc(C)c2c(n1)nn1c(NCCN3CCOCC3)cc(C)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c2c(n1)nn1c(NCCN3CCOCC3)cc(C)nc21
Cc1cc(C)c2c(n1)nn1c(NCCN3CCOCC3)cc(C)nc21
4,11,13-trimethyl-N-(2-morpholin-4-ylethyl)-3,7,8,10-tetrazatricyclo[7.4.0.02,7]trideca-1,3,5,8,10,12-hexaen-6-amine